Trademark: 79325238
Word

Status
Registered
Status Code
700
Status Date
Tuesday, September 20, 2022
Serial Number
79325238
Registration Number
6848933
Registration Date
Tuesday, September 20, 2022
Mark Type
2000
Filing Date
Thursday, July 8, 2021
Published for Opposition
Tuesday, July 5, 2022

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The mark consists of three partially overlapping hour-glass shaped segments that form an equilateral triangle tilted slightly to the left; the first segment overlaps the top of the third segment, is bordered in purple and transitions from magenta to light magenta, the second segment overlaps the bottom of the first segment and transitions from orange to light orange and the third segment overlaps the bottom of the second segment and is purple with two purple tabs on the top.
The color(s) purple, magenta, light magenta, orange and light orange is/are claimed as a feature of the mark.

Trademark Events
Feb 1, 2023
Final Decision Transaction Processed By Ib
Jan 11, 2023
Final Disposition Notice Sent To Ib
Jan 11, 2023
Final Disposition Processed
Dec 20, 2022
Final Disposition Notice Created, To Be Sent To Ib
Sep 20, 2022
Notice Of Registration Confirmation Emailed
Sep 20, 2022
Registered-Principal Register
Jul 19, 2022
Notification Processed By Ib
Jul 5, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 5, 2022
Published For Opposition
Jun 29, 2022
Notification Of Possible Opposition Sent To Ib
Jun 29, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 15, 2022
Notification Of Notice Of Publication E-Mailed
May 31, 2022
Approved For Pub - Principal Register
May 23, 2022
Teas/Email Correspondence Entered
May 23, 2022
Correspondence Received In Law Office
May 23, 2022
Teas Response To Office Action Received
May 1, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
May 1, 2022
Teas Change Of Correspondence Received
May 1, 2022
Teas Change Of Domestic Representatives Address
May 1, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 1, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 1, 2022
Teas Change Of Owner Address Received
Mar 8, 2022
Refusal Processed By Ib
Feb 15, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Feb 15, 2022
Refusal Processed By Mpu
Jan 25, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jan 24, 2022
Non-Final Action Written
Jan 21, 2022
Assigned To Examiner
Nov 23, 2021
Application Filing Receipt Mailed
Nov 18, 2021
New Application Office Supplied Data Entered
Nov 18, 2021
Limitation From Original Application Entered
Nov 11, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24